GtoPdb Ligand ID: 6941

Synonyms: GA-101 | GA101 | Gazyva®
obinutuzumab is an approved drug (FDA (2013), EMA (2014))
Compound class: Antibody
Comment: Obinutuzumab is a third-generation, humanized and glyco-engineered anti-CD20 IgG1 mAb. Prior to 2009 obinutuzumab was known as afutuzumab.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: obinutuzumab

Compound class Antibody
Approved drug? Yes (FDA (2013), EMA (2014))
International Nonproprietary Names
INN number INN
9043 obinutuzumab
GA-101 | GA101 | Gazyva®
Database Links
Specialist databases
IMGT/mAb-DB 238
Other databases
GtoPdb PubChem SID 178103523
PubChem SID 178103523
Search PubMed clinical trials obinutuzumab
Search PubMed titles obinutuzumab
Search PubMed titles/abstracts obinutuzumab
Wikipedia Obinutuzumab